Free Trial

Neuphoria Therapeutics (NEUP) Competitors

Neuphoria Therapeutics logo
$15.52 +0.35 (+2.31%)
As of 10/17/2025 04:00 PM Eastern

NEUP vs. ELDN, MIST, CCCC, CGEN, MCRB, NKTX, PEPG, ANRO, ANIX, and CRDF

Should you be buying Neuphoria Therapeutics stock or one of its competitors? The main competitors of Neuphoria Therapeutics include Eledon Pharmaceuticals (ELDN), Milestone Pharmaceuticals (MIST), C4 Therapeutics (CCCC), Compugen (CGEN), Seres Therapeutics (MCRB), Nkarta (NKTX), PepGen (PEPG), Alto Neuroscience (ANRO), Anixa Biosciences (ANIX), and Cardiff Oncology (CRDF). These companies are all part of the "pharmaceutical products" industry.

Neuphoria Therapeutics vs. Its Competitors

Neuphoria Therapeutics (NASDAQ:NEUP) and Eledon Pharmaceuticals (NASDAQ:ELDN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Neuphoria Therapeutics has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500. Comparatively, Eledon Pharmaceuticals has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500.

Neuphoria Therapeutics has higher revenue and earnings than Eledon Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neuphoria Therapeutics$15.65M2.34-$370KN/AN/A
Eledon PharmaceuticalsN/AN/A-$36.18M-$1.17-2.94

15.9% of Neuphoria Therapeutics shares are held by institutional investors. Comparatively, 56.8% of Eledon Pharmaceuticals shares are held by institutional investors. 0.7% of Neuphoria Therapeutics shares are held by insiders. Comparatively, 12.3% of Eledon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Eledon Pharmaceuticals had 4 more articles in the media than Neuphoria Therapeutics. MarketBeat recorded 4 mentions for Eledon Pharmaceuticals and 0 mentions for Neuphoria Therapeutics. Neuphoria Therapeutics' average media sentiment score of 0.00 beat Eledon Pharmaceuticals' score of -0.27 indicating that Neuphoria Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Neuphoria Therapeutics Neutral
Eledon Pharmaceuticals Neutral

Neuphoria Therapeutics presently has a consensus price target of $28.00, suggesting a potential upside of 80.41%. Eledon Pharmaceuticals has a consensus price target of $10.00, suggesting a potential upside of 190.70%. Given Eledon Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Eledon Pharmaceuticals is more favorable than Neuphoria Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neuphoria Therapeutics
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Eledon Pharmaceuticals
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Neuphoria Therapeutics' return on equity of -1.95% beat Eledon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Neuphoria TherapeuticsN/A -1.95% -1.47%
Eledon Pharmaceuticals N/A -92.51%-38.31%

Summary

Neuphoria Therapeutics and Eledon Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

Get Neuphoria Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEUP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEUP vs. The Competition

MetricNeuphoria TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$35.77M$3.39B$6.09B$10.49B
Dividend YieldN/A2.28%5.73%4.80%
P/E RatioN/A22.5884.9827.13
Price / Sales2.34267.64519.68179.70
Price / Cash97.3346.5937.1661.22
Price / Book1.5410.4112.236.52
Net Income-$370K-$52.47M$3.33B$276.93M
7 Day Performance-11.31%2.31%1.18%1.94%
1 Month Performance65.11%11.13%6.16%2.20%
1 Year PerformanceN/A11.12%60.00%35.02%

Neuphoria Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEUP
Neuphoria Therapeutics
2.1392 of 5 stars
$15.52
+2.3%
$28.00
+80.4%
N/A$35.77M$15.65M0.00N/A
ELDN
Eledon Pharmaceuticals
1.8139 of 5 stars
$2.74
-8.1%
$10.00
+265.0%
+22.4%$178.45MN/A-2.3410News Coverage
Gap Up
MIST
Milestone Pharmaceuticals
2.6938 of 5 stars
$1.99
-4.8%
$4.50
+126.1%
+32.0%$177.64M$1M-2.3730
CCCC
C4 Therapeutics
3.5495 of 5 stars
$2.25
-6.6%
$8.50
+277.8%
-63.0%$171.52M$35.58M-1.42150News Coverage
CGEN
Compugen
1.6298 of 5 stars
$1.85
-3.6%
$4.00
+116.2%
+8.4%$171.34M$27.86M-8.4170News Coverage
Gap Up
High Trading Volume
MCRB
Seres Therapeutics
2.3884 of 5 stars
$19.12
-1.9%
$14.33
-25.0%
+12.1%$170.71M$126.32M-4.16330
NKTX
Nkarta
2.4447 of 5 stars
$2.16
-8.5%
$13.50
+525.0%
-42.5%$167.62MN/A-1.46140Gap Down
PEPG
PepGen
3.0231 of 5 stars
$4.71
-6.5%
$8.40
+78.5%
-44.9%$164.98MN/A-1.5930Short Interest ↑
ANRO
Alto Neuroscience
1.9304 of 5 stars
$5.66
-5.9%
$9.80
+73.1%
-57.3%$163MN/A-2.37N/A
ANIX
Anixa Biosciences
2.8667 of 5 stars
$4.33
-12.0%
$9.00
+107.9%
+37.1%$161.95M$210K-12.375News Coverage
Analyst Forecast
High Trading Volume
CRDF
Cardiff Oncology
2.5436 of 5 stars
$2.21
-7.1%
$10.63
+380.8%
-21.5%$158.33M$680K-2.5420

Related Companies and Tools


This page (NASDAQ:NEUP) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners